A phase‐by‐phase review of migraine pathophysiology

DW Dodick - Headache: the journal of head and face pain, 2018 - Wiley Online Library
Migraine is a common, disabling neurological disorder characterized by multiple phases:
premonitory, aura, headache, postdrome, and interictal. Our understanding of the …

Pathophysiology, prevention, and treatment of medication overuse headache

HC Diener, D Dodick, S Evers, D Holle… - The Lancet …, 2019 - thelancet.com
Regular or frequent use of analgesics and acute antimigraine drugs can increase the
frequency of headache, and induce the transition from episodic to chronic headache or …

Dual and opposing functions of the central amygdala in the modulation of pain

TD Wilson, S Valdivia, A Khan, HS Ahn, AP Adke… - Cell reports, 2019 - cell.com
Pain perception is essential for survival and can be amplified or suppressed by
expectations, experiences, and context. The neural mechanisms underlying bidirectional …

Amygdala, neuropeptides, and chronic pain-related affective behaviors

V Neugebauer, M Mazzitelli, B Cragg, G Ji… - …, 2020 - Elsevier
Neuropeptides play important modulatory roles throughout the nervous system, functioning
as direct effectors or as interacting partners with other neuropeptide and neurotransmitter …

Endogenous and exogenous opioids in pain

G Corder, DC Castro, MR Bruchas… - Annual review of …, 2018 - annualreviews.org
Opioids are the most commonly used and effective analgesic treatments for severe pain, but
they have recently come under scrutiny owing to epidemic levels of abuse and overdose …

Five decades of research on opioid peptides: current knowledge and unanswered questions

LD Fricker, EB Margolis, I Gomes, LA Devi - Molecular pharmacology, 2020 - ASPET
In the mid-1970s, an intense race to identify endogenous substances that activated the
same receptors as opiates resulted in the identification of the first endogenous opioid …

Dysregulation of serum prolactin links the hypothalamus with female nociceptors to promote migraine

M Watanabe, CM Kopruszinski, A Moutal, D Ikegami… - Brain, 2022 - academic.oup.com
Migraine headache results from activation of meningeal nociceptors, however, the
hypothalamus is activated many hours before the emergence of pain. How hypothalamic …

Migraine treatment: Towards new pharmacological targets

M Silvestro, LF Iannone, I Orologio, A Tessitore… - International Journal of …, 2023 - mdpi.com
Migraine is a debilitating neurological condition affecting millions of people worldwide. Until
a few years ago, preventive migraine treatments were based on molecules with pleiotropic …

Ubrogepant does not induce latent sensitization in a preclinical model of medication overuse headache

E Navratilova, S Behravesh, J Oyarzo… - …, 2020 - journals.sagepub.com
Background Ubrogepant, a small-molecule calcitonin gene-related peptide receptor
antagonist, was recently approved as an oral medication for the acute treatment of migraine …

Kappa opioid signaling in the central nucleus of the amygdala promotes disinhibition and aversiveness of chronic neuropathic pain

E Navratilova, G Ji, C Phelps, C Qu, M Hein… - Pain, 2019 - journals.lww.com
Chronic pain is associated with neuroplastic changes in the amygdala that may promote
hyper-responsiveness to mechanical and thermal stimuli (allodynia and hyperalgesia) …